BRA
MRK icon

Bender Robert & Associates’s Merck MRK Stock Holding History

Bender Robert & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,343
Closed -$661K – 67
2024
Q2 		$661K Buy
+5,343
New +$688K 0.15% 30

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bender Robert & Associates's MRK Position: Q2 2026 in Review

Bender Robert & Associates reduced its Merck (MRK) stake by 0.86% in Q2 2026, selling an estimated $4.1K and leaving 4,042 shares worth $519K. The position accounts for 0.11% of the portfolio, ranked #32.

Bender Robert & Associates first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $953K in Q4 2022. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bender Robert & Associates held 4,042 shares of Merck worth $519K as of Q2 2026.
  • Bender Robert & Associates sold 35 Merck shares in Q2 2026, an estimated $4.1K.
  • Merck made up 0.11% of Bender Robert & Associates's portfolio in Q2 2026, its #32 holding.
  • Bender Robert & Associates first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Bender Robert & Associates's Merck position peaked at $953K in Q4 2022.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bender Robert & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.